Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DPZK | ISIN: SE0005881786 | Ticker-Symbol: 725
Frankfurt
17.01.25
09:16 Uhr
0,441 Euro
+0,083
+23,22 %
Branche
Maschinenbau
Aktienmarkt
Sonstige
1-Jahres-Chart
OPTICEPT TECHNOLOGIES AB Chart 1 Jahr
5-Tage-Chart
OPTICEPT TECHNOLOGIES AB 5-Tage-Chart
GlobeNewswire (Europe)
7 Leser
Artikel bewerten:
(0)

OptiCept Technologies AB: OptiCept Reports Strong Interim Results from Project in South Africa

Finanznachrichten News

OptiCept announced today that the company has achieved excellent results in its ongoing project with several prominent forestry companies in South Africa. Using the company's technology, they have successfully increased the rooting rate for eucalyptus cuttings by an average of at least 77% per customer, far exceeding the project's objectives at this stage.

The project, initiated in the fall of 2024, aims to accelerate the commercialization of the OptiBoost technology in the South African market. OptiCept has conducted tests with the majority of the eight participating customers and has now received interim results from the largest of these clients. So far, the results are considered very positive and beyond expectations.

"These are excellent results and everything we could have hoped for at this stage of the project. We have continuously refined the method and learned a great deal since its launch. We have also engaged local experts who, in collaboration with our staff, work closely with the customers. Altogether, this allows us to accelerate progress toward commercial agreements," says Thomas Lundqvist, CEO of OptiCept Technologies.

Among the participating companies is Mondi Group, with which OptiCept has previously collaborated. Mondi is a multinational packaging and paper company, recognized as a global leader in its field and listed on the Johannesburg Stock Exchange and London Stock Exchange. Mondi plants around 20 million cuttings annually.

Another participant is Sappi, a leading global supplier of wood fiber-based products. Sappi has 11,600 employees worldwide and operates manufacturing facilities on three continents (eight in Western Europe, four in North America, and five in Southern Africa). Sappi plants approximately 27 million cuttings annually.

Other companies involved in the project include Sutherland Seedlings, Ezigro, Du Roi Multiplant, York Timbers, CPS Seedlings, and TWK Agri, collectively producing over 33 million cuttings annually.

The South African forestry sector (forestry and forest products) is globally prominent and therefore represents an important market for OptiCept. The country currently has approximately 1.2 million hectares of cultivated forest, primarily eucalyptus and pine, as well as acacia.

With the OptiBoost technology, OptiCept aims to enhance efficiency within the forestry industry. By increasing rooting rates with the patented vacuum impregnation technology, more cuttings can be rooted, allowing more trees to be planted and delivering greater returns for the industry.

Contacts

For further information, please contact:

Thomas Lundqvist, CEO
+46 73 268 05 70
Thomas.Lundqvist@opticept.se

Déspina Georgiadou Hedin, CFO
+46 76 569 78 73
Despina.georgiadou@opticept.se

About Us

OptiCept Technologies AB (publ) provides the food and plant industry with technological solutions that contribute to a more sustainable world and enable climate-smart economic growth. OptiCept optimizes biological processes - Increased extraction from raw material, extended shelf life, reduced waste, and improved quality (taste, aroma, color, nutritional content) of the final product.

The positive effects of technology increase efficiency for our customers, better products for the consumers, and minimal impact on our environment. Through patented technology in PEF (pulsed electric field) and VI (Vacuum Infusion), the technology opens up new business opportunities for the food and plant industry worldwide. OptiCept's vision is to contribute to a sustainable world by offering efficient green cutting-edge technology that is easy to use in the areas of FoodTech and PlantTech.

The company is located in Lund and the share is traded on the Nasdaq First North Growth Market (ticker: OPTI). The Company's Certified Adviser is Carnegie Investment Bank AB (publ).

For further information visit:
OptiCept Technologies Official Website

© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.